Document is current
Any future updates will be listed below
-
Authors
Halligan, Rebecca K. https://orcid.org/0000-0002-0352-9482
Dalton, R. Neil
Turner, Charles
Lewis, Katherine A.
Mundy, Helen R.
-
Funding
Funding for this research was provided by:
Glyde Study
- License Information
-
More Information
Article History
Received: 14 January 2022
Accepted: 26 April 2022
First Online: 12 May 2022
Declarations
:
: Informed verbal consent for the off-label use of empagliflozin was obtained from the parents of our patients prior to treatment commencement. This is a retrospective collection of anonymized data collected during routine patient care which, in line with the declaration of Helsinki, neither individual patients consents nor formal research ethics committee approval was required.
: All patients provided written consent for publication.
: The authors declare they have no competing interests.
